The 13 policies your 17M-13 asks about, and the law behind each one.

2 days ago

7 min read

"We have a policy binder. Can't I just check yes on all of Section 8 and move on?"

I hear some version of that every time a self-assessment comes due. There usually is a binder. The question is whether it was written for this pharmacy, this PIC, and all thirteen subjects the form asks about.

So the honest answer is no. A "yes" in Section 8 is not a statement that your staff knows what to do. It is a statement that the pharmacy has policies and procedures covering that subject, and you are signing it under penalty of perjury. Here is the whole list, the law the Board cites for each item, and what the regulations themselves say a few of these policies must contain.

Why Section 8 deserves more than a pen

The current Community Pharmacy Self-Assessment/Hospital Outpatient Pharmacy Self-Assessment, form 17M-13, carries an approval date of 1/27/2026. Its instructions restate the schedule from Business and Professions Code section 4102: the PIC completes the assessment by July 1 of every odd-numbered year, and also within 30 days of a new pharmacy license, a change of PIC, or a move to a new address.

Three instructions on the first page matter for Section 8:

A "No" requires an explanation in the "Corrective Action Plan" column.
"N/A" is only for a requirement that "clearly and objectively does not apply to your pharmacy."
A new form must be filled out each time, and the form says "do not use or copy from a previous self-assessment form."

Then there is the last page. The PIC certifies "under penalty of perjury" that the information is true and correct, commits to a date by which any deficiency "will be corrected," and acknowledges the assessment will be readily available during any Board inspection. The owner or hospital administrator signs too, acknowledging that "failure to correct any deficiency identified in this self-assessment could result in action by the California State Board of Pharmacy." The completed form stays in the pharmacy for three years.

That is a lot of weight to put on a box you checked because a binder exists.

The list, exactly as the form states it

Section 8 opens with one line: "The pharmacy has policies and procedures covering the following matters." Then come thirteen items, each with its reference.

8.1 (BPC 4104). Protecting the public when a licensed individual is impaired.
8.2 (BPC 4104). Protecting the public when a licensed individual has engaged in theft, diversion, or self-use of dangerous drugs.
8.3 (16 CCR 1714.1). Operations during the pharmacist's breaks and meal periods.
8.4 (16 CCR 1717.1; Civil Code 56.10 and 56.101). Confidentiality of medical information.
8.5 (BPC 4059.5). Delivery of dangerous drugs to a secure storage facility when the pharmacy is closed.
8.6 (BPC 733). Timely patient access despite a pharmacist's refusal to dispense on ethical, moral, or religious grounds.
8.7 (16 CCR 1707.5). Helping patients with limited or no English proficiency understand the label.
8.8 (16 CCR 1715.65). Inventory reconciliation reporting requirements.
8.9 (BPC 4081; 16 CCR 1793.7). Pharmacy personnel and operations.
8.10 (16 CCR 1717.5). Auto-refill program.
8.11 (16 CCR 1711). Quality assurance for medication errors.
8.12 (BPC 4113.5; 16 CCR 1714.3). Community pharmacy staffing.
8.13 (BPC 4119.3). Repackaging services. The form footnotes this reference as "Formerly BPC 4052.7."

The form header says "policies and procedures," not "written." But for at least five of these items, the law behind the line does say written, and often says what the document must cover. Those are the ones I check first on site.

Impairment and diversion: two policies, one statute, a 14-day clock

Items 8.1 and 8.2 both point to Business and Professions Code section 4104.

Subdivision (b) is plain: "Every pharmacy shall have written policies and procedures for addressing chemical, mental, or physical impairment, as well as theft, diversion, or self-use of dangerous drugs, among licensed individuals employed by or with the pharmacy."

The policy is only half of 4104. Subdivision (c) requires the pharmacy to report to the Board within 14 days of receiving or developing any of six things: an admission of impairment, an admission of theft, diversion, or self-use, video or documentary evidence of either, or a termination based on either. Under subdivision (d), the report includes an estimate of the type and quantity of drugs involved, the timeframe of the suspected losses, and the date of the last controlled substances inventory.

What I look for is whether the policy tells the person in charge on a bad Tuesday who gets told, who secures the evidence, who files with the Board, and who is watching the 14 days. "The pharmacy will comply with section 4104" does not do that.

Breaks and meals: the regulation writes the outline for you

Item 8.3 cites 16 CCR 1714.1, as published in the Board's 2026 Pharmacy Lawbook. Subdivision (f) requires written policies and procedures on operations during the pharmacist's temporary absence for breaks and meal periods, and it names the minimum content: "the authorized duties of ancillary staff, the pharmacist's responsibilities for checking all work performed by ancillary staff and the pharmacist's responsibility for maintaining the security of the pharmacy." The policies must be "open to inspection by the board or its designee at all times during business hours."

The rest of the section supplies the substance:

Under 1714.1(b), no prescription goes out unless it is a refill the pharmacist already checked, released, and determined needs no consultation.
Under 1714.1(c), ancillary staff may keep doing non-discretionary duties, but a pharmacist reviews all of it on return.
Under 1714.1(d), an intern may not act as a pharmacist during the absence.
Under 1714.1(e), any meal is limited to 30 minutes.

Subdivision (g) defines ancillary staff to include interns, technicians, trainees, and non-licensed personnel. A policy that only mentions technicians is narrower than the regulation.

Inventory reconciliation: the policy is where the definitions live

Item 8.8 cites 16 CCR 1715.65, and this is the one I spend the most time on. Subdivision (b) says: "Written policies and procedures shall be developed for performing the inventory activities and preparing the inventory reconciliation reports required by this section." The PIC reviews all of it and must "establish and maintain secure methods to prevent losses."

The reason this policy matters more than most is that the regulation hands two definitions to it.

First, under 1715.65(a)(3)(A), a reportable loss is at minimum what section 1715.6 specifies, "or any pattern(s) of loss(es) identified by the pharmacist in charge, as defined by the pharmacy's policies and procedures." If your policy does not define a pattern of loss, you have left part of your own reporting trigger blank.

Second, under 1715.65(a)(3)(B), "inventory activities" means inventory plus "all other functions sufficient to identify loss of controlled substances," and "the functions sufficient to identify loss outside of the inventory reconciliation process shall be identified within the pharmacy's policies and procedures."

The schedule the policy has to support is set in subdivision (a):

Federal Schedule II controlled substances: a reconciliation report at least once every three months.
Alprazolam 1 mg and 2 mg, tramadol 50 mg, and promethazine/codeine (6.25 mg/10 mg per 5 mL): at least once every 12 months.
Every other controlled substance: inventory activities at least once every two years, plus a reconciliation report no later than three months after discovery of a reportable loss.

Subdivision (c) requires a physical count, "not an estimate," a review of acquisitions and dispositions, a comparison to find variances, and identification of the records used. Subdivision (e)(2) keeps the report and its records readily retrievable for three years. And subdivision (f) catches new PICs: a new pharmacist-in-charge completes a reconciliation report for the Schedule II and listed substances within 30 days of taking over. That 30-day window lines up with the 30-day self-assessment, so a PIC change is two deadlines, not one.

Clocks behind Section 8: a 14-day Board report under BPC 4104(c), a 30-day reconciliation for a new PIC, quarterly Schedule II reconciliation, and 12-month reconciliation for the listed drugs under 16 CCR 1715.65

Quality assurance and auto-refill: written, retrievable, specific

Item 8.11 cites 16 CCR 1711. Under 1711(c)(1), the quality assurance program "shall be managed in accordance with written policies and procedures maintained in the pharmacy in an immediately retrievable form." The policy should track the rest of the section, including 1711(d): each medication error investigation starts no later than 2 business days after discovery. Subdivision (g) says the Board will consider compliance a mitigating factor when it investigates an error. That is the practical reason to get this one right.

Item 8.10 cites 16 CCR 1717.5. If you run an automatic refill program, 1717.5(a)(1) requires written policies that "set forth, at a minimum, how the pharmacy will comply with this section": enrollment consent, annual renewal, regimen review at each refill, notification, disenrollment, and refunds. If you do not run a program, this is one of the few places where N/A is honest.

Refusal to dispense: the employer owes a protocol

Item 8.6 cites Business and Professions Code section 733. Section 733(b)(3) lets a licentiate decline to dispense on ethical, moral, or religious grounds only if the licentiate previously notified the employer in writing of the drug or class of drugs, and the employer can reasonably accommodate the objection without undue hardship. It then puts the duty on the employer: "The licentiate's employer shall establish protocols that ensure that the patient has timely access to the prescribed drug or device despite the licentiate's refusal to dispense the prescription or order."

So the policy for 8.6 is really two things: a way to collect and keep those written notices, and a workflow that gets the patient the drug on time when the objecting pharmacist is the only one on duty.

How I set this up with clients

The approach that holds up is boring on purpose:

One policy per line item. Each names the 17M-13 item it answers and the section it rests on.
Use the regulation's own outline. Where the law lists required content, as 1714.1(f), 1715.65(a)(3) and 1717.5(a) do, build the headings from it.
Review it with the assessment. When you complete the 17M-13, re-read the policy behind every Section 8 "yes."
Let a "No" be a No. Write the corrective action and put a real date in the certification. A "No" with a plan beats a "yes" you cannot back up.

If you would like a set built that way, with each policy keyed to its 17M-13 line, that is the approach behind our pharmacy policies and procedures work.

And if you are looking at Section 8 right now and are not sure your binder would survive an inspector reading it, send me the table of contents and I will tell you what I see. Reach out if you have any questions or concerns.

Sources

California State Board of Pharmacy, Community Pharmacy Self-Assessment/Hospital Outpatient Pharmacy Self-Assessment, form 17M-13 (approved 1/27/2026), including Section 8 and the PIC certification and owner acknowledgment.
Business and Professions Code section 4104 (impairment and diversion policies; 14-day report to the Board).
Business and Professions Code section 733 (dispensing; refusal on ethical, moral or religious grounds; employer protocols).
California Code of Regulations, title 16, sections 1711 (quality assurance programs), 1714.1 (operations during the temporary absence of a pharmacist), 1715.65 (inventory activities and reconciliation reports) and 1717.5 (automatic refill programs), as published in the Board's 2026 Pharmacy Lawbook.

General information from a consultant pharmacist, not legal advice. Statutes and forms change; everything above was checked against the official source on the date of publication.